The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Self-citation(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00967-9 · Cited by 814
Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666
RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., IIDA, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K. B., Sorenson, J., Orlock, D., & Borodoker, N. (2012) · Retina · doi:10.1097/iae.0b013e31823f9b3b · Cited by 660
RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
YANNUZZI, L. A., NEGRÃO, S., IIDA, T., CARVALHO, C., RODRIGUEZ-COLEMAN, H., SLAKTER, J., FREUND, K. B., SORENSON, J., ORLOCK, D., & BORODOKER, N. (2001) · Retina · doi:10.1097/00006982-200110000-00003 · Cited by 659
SPAIDE, R. F., LAUD, K., FINE, H. F., KLANCNIK, J. M., MEYERLE, C. B., YANNUZZI, L. A., SORENSON, J., SLAKTER, J., FISHER, Y. L., & COONEY, M. J. (2006) · Retina · doi:10.1097/00006982-200604000-00001 · Cited by 630
Kvanta, A., Algvere, P., Berglin, L., & Seregard, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70522-7 · Cited by 620
Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7788 · Cited by 604
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590
Beer, P. M., Bakri, S. J., Singh, R. J., Liu, W., Peters, G. B., & Miller, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01969-3 · Cited by 570
Blaauwgeers, H. G. T., Holtkamp, G. M., Rutten, H., Witmer, A. N., Koolwijk, P., Partanen, T. A., Alitalo, K., Kroon, M. E., Kijlstra, A., van Hinsbergh, V. W. M., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65138-3 · Cited by 520
Increased expression of angiogenic growth factors in age-related maculopathy
Kliffen, M., Sharma, H. S., Mooy, C. M., Kerkvliet, S., & de Jong, P. T. V. M. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.2.154 · Cited by 502
RICH, R. M., ROSENFELD, P. J., PULIAFITO, C. A., DUBOVY, S. R., DAVIS, J. L., FLYNN, H. W., GONZALEZ, S., FEUER, W. J., LIN, R. C., LALWANI, G. A., et al. (2006) · Retina · doi:10.1097/01.iae.0000225766.75009.3a · Cited by 484
Self-citationGragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, H. W., McKay, P., de Vos, A. M., & Lowman, H. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3192 · Cited by 448
THE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Elliott, W. J. (2006) · Yearbook of Cardiology · doi:10.1016/s0145-4145(07)70004-7 · Cited by 390
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.11.1621 · Cited by 374
FRANK, R. N., AMIN, R. H., ELIOTT, D., PUKLIN, J. E., & ABRAMS, G. W. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)72066-5 · Cited by 366
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Heier, J. S., Antoszyk, A. N., Pavan, P. R., Leff, S. R., Rosenfeld, P. J., Ciulla, T. A., Dreyer, R. F., Gentile, R. C., Sy, J. P., Hantsbarger, G., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.052 · Cited by 360
Self-citationTHE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
ADAMIS, A. P., & SHIMA, D. T. (2005) · Retina · doi:10.1097/00006982-200502000-00001 · Cited by 334
Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1996) · PubMed · Cited by 332
Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Noe¨l, A., & Munaut, C. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1092 · Cited by 321
Epidemiology of Age-Related Macular Degeneration
Klein, R. (2005) · Macular Degeneration · doi:10.1007/3-540-26977-0_5 · Cited by 283
Spaide, R. F., Sorenson, J., & Maranan, L. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00544-x · Cited by 272
VERTEPORFIN ROUNDTABLE 2000 AND 2001 PARTICIPANTS, T. O. A.-R. M. D. W. P. T. (. S. G. P. I. (2002) · Retina · doi:10.1097/00006982-200202000-00003 · Cited by 246
Saishin, Y., Saishin, Y., Takahashi, K., Silva, R. L. E., Hylton, D., Rudge, J. S., Wiegand, S. J., & Campochiaro, P. A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10246 · Cited by 239
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1253 · Cited by 213
Pathogenesis of lesions in late age-related macular disease
Holz, F. G., Pauleikhoff, D., Klein, R., & Bird, A. C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.026 · Cited by 203
Rosenfeld, P. J., Heier, J. S., Hantsbarger, G., & Shams, N. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.027 · Cited by 189
Self-citationSeo, M. S., Kwak, N., Ozaki, H., Yamada, H., Okamoto, N., Yamada, E., Fabbro, D., Hofmann, F., Wood, J. M., & Campochiaro, P. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65430-2 · Cited by 169
Rechtman, E., Danis, R. P., Pratt, L. M., & Harris, A. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.027177 · Cited by 146
Otani, A., Takagi, H., Oh, H., Koyama, S., Ogura, Y., Matumura, M., & Honda, Y. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2407 · Cited by 128
Bevacizumab for Patients with Metastatic Renal Cancer
Yang, J. C.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050006 · Cited by 128
Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Folk, J. C., & Stone, E. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmct1000495 · Cited by 99
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration
Jonas, J. B. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01423-x · Cited by 68
Tolentino, M. J. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.1.78 · Cited by 50
Ocular angiogenesis: translating preclinical indications to successful clinical development
Konerding, M. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.3.255 · Cited by 16
Choti, M. A. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.09.003 · Cited by 7
Photodynamic Therapy of Subfoveal Choroidal Neovascularization with Verteporfin
Kertes, P. J. (2004) · Evidence-Based Eye Care · doi:10.1097/00132578-200401000-00005 · Cited by 5
Cited by
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Self-citationFERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Metadata
- Authors
- MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 112
- Issue
- 6
- Pages
- 1035-1047.e9
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2058775052
- Cited by
- 664
- References
- 60
- FWCI
- 68.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.